ERBB2 and head and neck squamous cell carcinoma: In HNSCC, targets include the epidermal growth factor receptor (EGFR), phosphoinositide-3 kinase (PI3K), human epidermal growth factor receptor 2 (HER2), and vascular endothelial growth factor receptor (VEGFR).